<?xml version="1.0" encoding="UTF-8"?>
<p>Umifenovir (Arbidol) has an effect against influenza viruses and the mechanism of antiviral action is based on blocking the penetration of the virus into cells (fusion inhibitor) and the immunomodulatory effect (
 <xref rid="B56" ref-type="bibr">56</xref>). One of its advantages is its reduced side effects. Umifenovir has been tested in combination with other antivirals in patients with uncomplicated pneumonia with COVID-19 (
 <xref rid="B57" ref-type="bibr">57</xref>).
</p>
